Novo Nordisk says US peptide craze boosting Wegovy weight-loss pill sales
Financial Times1 min readPaywall
Read Full Article at Financial Times →Ad Slot — In-Article (728x90)
Drugmaker lifts sales and profit forecasts in wake of strong demand for GLP-1 anti-obesity drugs
This is a summary. For the full story, read the original article at Financial Times.
Original source: Financial Times